Cognitive Function and Quality of Life in Vorinostat-Treated Patients Following Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplant

Myeloablative conditioning allogeneic hematopoietic cell transplantation (HCT) puts patients at greater risk for significant cognitive and quality of life decline compared with recipients of reduced intensity conditioning or autologous HCT. Vorinostat, an HDAC inhibitor, has been shown to have neuro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biol Blood Marrow Transplant
Päätekijät: Hoodin, Flora, LaLonde, Leah, Errickson, Josh, Votruba, Kristen, Kentor, Rachel, Gatza, Erin, Reddy, Pavan, Choi, Sung Won
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339826/
https://ncbi.nlm.nih.gov/pubmed/30244099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.09.015
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia